# HS6ST1

## Overview
HS6ST1 (heparan sulfate 6-O-sulfotransferase 1) is a gene that encodes an enzyme involved in the post-translational modification of heparan sulfate (HS), a glycosaminoglycan that plays a pivotal role in various biological processes. The enzyme, categorized as a sulfotransferase, specifically catalyzes the 6-O-sulfation of glucosamine residues within HS chains, a modification critical for the structural and functional diversity of HS. This enzymatic activity is essential for modulating interactions between HS and a range of ligands, thereby influencing cellular communication, tissue development, and processes such as angiogenesis and neural patterning (Ushakov2017Heparan; Zhao2019Changes). HS6ST1 is predominantly active in the Golgi apparatus, where it contributes to the biosynthesis of HS, impacting developmental pathways and physiological functions (Fuster2010Endothelial). Mutations in the HS6ST1 gene have been linked to developmental disorders, highlighting its significance in human health and disease (Tornberg2011Heparan; Howard2018HS6ST1).

## Function
HS6ST1 (heparan sulfate 6-O-sulfotransferase 1) is an enzyme that plays a critical role in the biosynthesis of heparan sulfate (HS) by catalyzing the 6-O-sulfation of glucosamine residues. This modification is essential for the structural diversity and biological activity of HS, influencing its ability to bind specific ligands and mediate cell-cell and cell-matrix interactions (Ushakov2017Heparan). HS6ST1 is active in the Golgi apparatus, where it modifies HS chains, impacting processes such as angiogenesis and neural patterning (Zhao2019Changes).

In the context of angiogenesis, HS6ST1 regulates the interaction between HS and various growth factors, including VEGF-A, a potent inducer of angiogenesis. This regulation is crucial for proper vascular development, as evidenced by studies showing that HS6ST1 deficiency leads to impaired placental function and embryonic lethality due to reduced fetal microvessels and hypoxia (Fuster2010Endothelial). The enzyme's activity is vital for modulating growth factor signaling pathways, which are essential for developmental angiogenesis and vascular morphogenesis (Fuster2010Endothelial).

Overall, HS6ST1 is integral to maintaining normal physiological processes by ensuring the proper sulfation of HS, which is necessary for effective cellular communication and tissue development.

## Clinical Significance
Mutations in the HS6ST1 gene are clinically significant as they are associated with several developmental disorders, primarily affecting puberty and reproductive function. One notable condition linked to HS6ST1 mutations is self-limited delayed puberty (DP). The p.Arg375His variant in HS6ST1 has been identified in individuals with DP, showing an autosomal-dominant inheritance pattern. This mutation results in reduced sulfotransferase activity, which is crucial for normal puberty onset, although it does not affect adult fertility (Howard2018HS6ST1; Festa2020Genetic).

HS6ST1 mutations are also implicated in idiopathic hypogonadotropic hypogonadism (IHH), a condition characterized by a deficiency in gonadotropin-releasing hormone (GnRH) leading to incomplete sexual maturation and infertility. These mutations can result in varying phenotypes, including Kallmann syndrome, which involves olfactory dysfunction. The clinical presentation of IHH associated with HS6ST1 mutations is heterogeneous, with some patients exhibiting normal or abnormal olfactory structures (Tornberg2011Heparan).

The gene's role in extracellular sugar modifications suggests that its mutations may disrupt ligand-receptor interactions crucial for GnRH biology, contributing to the pathogenesis of these conditions (Tornberg2011Heparan). The inheritance patterns of these mutations are complex, indicating potential interactions with other genetic or epigenetic factors (Tornberg2011Heparan).


## References


[1. (Tornberg2011Heparan) Janne Tornberg, Gerasimos P. Sykiotis, Kimberly Keefe, Lacey Plummer, Xuan Hoang, Janet E. Hall, Richard Quinton, Stephanie B. Seminara, Virginia Hughes, Guy Van Vliet, Stan Van Uum, William F. Crowley, Hiroko Habuchi, Koji Kimata, Nelly Pitteloud, and Hannes E. Bülow. Heparan sulfate 6-o-sulfotransferase 1 , a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proceedings of the National Academy of Sciences, 108(28):11524–11529, June 2011. URL: http://dx.doi.org/10.1073/pnas.1102284108, doi:10.1073/pnas.1102284108. This article has 135 citations.](https://doi.org/10.1073/pnas.1102284108)

[2. (Ushakov2017Heparan) Victor Ushakov, Alexandra Tsidulko, Gabin De La Bourdonnaye, Galina Kazanskaya, Alexander Volkov, Roman Kiselev, Vyacheslav Kobozev, Diana Kostromskaya, Alexey Gaytan, Alexei Krivoshapkin, Svetlana Aidagulova, and Elvira Grigorieva. Heparan sulfate biosynthetic system is inhibited in human glioma due to ext1/2 and hs6st1/2 down-regulation. International Journal of Molecular Sciences, 18(11):2301, November 2017. URL: http://dx.doi.org/10.3390/ijms18112301, doi:10.3390/ijms18112301. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms18112301)

[3. (Fuster2010Endothelial) Mark M. Fuster and Lianchun Wang. Endothelial Heparan Sulfate in Angiogenesis, pages 179–212. Elsevier, 2010. URL: http://dx.doi.org/10.1016/S1877-1173(10)93009-3, doi:10.1016/s1877-1173(10)93009-3. This article has 97 citations.](https://doi.org/10.1016/S1877-1173(10)93009-3)

[4. (Zhao2019Changes) Shancheng Zhao and Zhen Wang. Changes in heparan sulfate sulfotransferases and cell-surface heparan sulfate during skm-1 cells granulocytic differentiation and a549 cells epithelial-mesenchymal transition. Glycoconjugate Journal, 37(2):151–164, December 2019. URL: http://dx.doi.org/10.1007/s10719-019-09903-0, doi:10.1007/s10719-019-09903-0. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10719-019-09903-0)

[5. (Howard2018HS6ST1) Sasha R Howard, Roberto Oleari, Ariel Poliandri, Vasiliki Chantzara, Alessandro Fantin, Gerard Ruiz-Babot, Louise A Metherell, Claudia P Cabrera, Michael R Barnes, Karoliina Wehkalampi, Leonardo Guasti, Christiana Ruhrberg, Anna Cariboni, and Leo Dunkel. Hs6st1 insufficiency causes self-limited delayed puberty in contrast with other gnrh deficiency genes. The Journal of Clinical Endocrinology &amp; Metabolism, 103(9):3420–3429, June 2018. URL: http://dx.doi.org/10.1210/jc.2018-00646, doi:10.1210/jc.2018-00646. This article has 36 citations.](https://doi.org/10.1210/jc.2018-00646)

[6. (Festa2020Genetic) Adalgisa Festa, Giuseppina Rosaria Umano, Emanuele Miraglia del Giudice, and Anna Grandone. Genetic evaluation of patients with delayed puberty and congenital hypogonadotropic hypogonadism: is it worthy of consideration? Frontiers in Endocrinology, May 2020. URL: http://dx.doi.org/10.3389/fendo.2020.00253, doi:10.3389/fendo.2020.00253. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2020.00253)